Trials / Unknown
UnknownNCT05838833
Ointment to Prevent Scar After Thyroidectomy
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of INV-001 Administration for the Prevention of Scar After Thyroidectomy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- Innovo Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate the efficacy and Safety of INV-001 administration for the prevention of scar after thyroidectomy. Participants will be asked to apply ointment on their scar for 12 weeks.
Detailed description
to evaluate the efficacy -investigator check POSAS and VSS
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | INV-001 | Patient will be assigned to one of three arms. |
Timeline
- Start date
- 2023-02-14
- Primary completion
- 2023-12-01
- Completion
- 2024-06-01
- First posted
- 2023-05-03
- Last updated
- 2023-05-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05838833. Inclusion in this directory is not an endorsement.